Methylated DNA as a possible screening marker for neoplastic disease in several body fluids (Q35183646)

7 August 2017

1 reference

title

Methylated DNA as a possible screening marker for neoplastic disease in several body fluids (English)

1 reference

7 August 2017

Hannes M Müller

1 reference

7 August 2017

Martin Widschwendter

series ordinal

1 reference

7 August 2017

publication date

1 July 2003

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

7 August 2017

published in

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

7 August 2017

page(s)

443-458

1 reference

The case for early detection

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

DNA methylation and breast carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

Cancer epigenetics comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

DNA methylation patterns and epigenetic memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

Worms gang up on bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

The power and the promise of DNA methylation markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

COBRA: a sensitive and quantitative DNA methylation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

MethyLight: a high-throughput assay to measure DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

Methylation and silencing of the Thrombospondin-1 promoter in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

Methylation mechanisms in pituitary tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

CDKN2A/p16 inactivation is related to pituitary adenoma type and size

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

Quantitative CSF PCR in Epstein-Barr virus infections of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

Patterns of gene promoter methylation in squamous cell cancer of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

DNA methylation analysis: a powerful new tool for lung cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

Evolution of neoplastic cell lineages in Barrett oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

Methylation and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

Detection of APC mutations in fecal DNA from patients with colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

CpG island methylation in carcinoid and pancreatic endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

DNA alterations in body fluids as molecular tumor markers for urological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

Differences in p16 gene methylation and expression in benign and malignant ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

Molecular detection of tumour DNA in serum and peritoneal fluid from ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

Phases of biomarker development for early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.3.4.443

21 January 2018

Identifiers

DOI

10.1586/14737159.3.4.443

1 reference

7 August 2017

1 reference